ES2140541T3 - Agente terapeutico. - Google Patents

Agente terapeutico.

Info

Publication number
ES2140541T3
ES2140541T3 ES94918690T ES94918690T ES2140541T3 ES 2140541 T3 ES2140541 T3 ES 2140541T3 ES 94918690 T ES94918690 T ES 94918690T ES 94918690 T ES94918690 T ES 94918690T ES 2140541 T3 ES2140541 T3 ES 2140541T3
Authority
ES
Spain
Prior art keywords
inflammatory
xii
mixtures
compound
plant extracts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94918690T
Other languages
English (en)
Inventor
Brian Daunter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAIN CAMP MARKETING Pty Ltd
Original Assignee
MAIN CAMP MARKETING Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAIN CAMP MARKETING Pty Ltd filed Critical MAIN CAMP MARKETING Pty Ltd
Application granted granted Critical
Publication of ES2140541T3 publication Critical patent/ES2140541T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

UN METODO PARA EL TRATAMIENTO DE UNA ENFERMEDAD INFLAMATORIA QUE CONSISTE EN ADMINISTRAR UN COMPUESTO DE LAS FORMULAS GENERALES (I A VII) DESCRITAS AQUI DENTRO EN LA FIGURA O DE MEZCLAS DE LAS MISMAS A UN SUJETO QUE PADECE UNA ENFERMEDAD INFLAMATORIA. TAMBIEN SE PRESENTA UN AGENTE TERAPEUTICO PARA EL ALIVIO DE ENFERMEDADES INFLAMATORIAS QUE INCLUYE UN COMPUESTO DE LAS FORMULAS GENERALES (I A XII) COMO LAS DESCRITAS EN LA FIGURA O MEZCLAS DE LAS MISMAS EN COMBINACION CON UNA SUSTANCIA DE RELLENO APROPIADA QUE PREFERENTEMENTE ES FOSFATO DICALCICO. DENTRO DEL ALCANCE DE LA INVENCION, TAMBIEN SE PRESENTAN EXTRACTOS DE PLANTAS QUE PUEDEN CONTENER UNO O MAS DE LOS COMPUESTOS ARRIBA MENCIONADOS Y EN PARTICULAR EXTRACTOS DE PLANTAS DEL GENERO UMBELLIFERAE, APIO (APIUM GRAVEOLENS), PEREJIL (PETROSELIMUN HORTENSE) Y ENELDO (ANETHUM GRAVEOLENS). SE CREE QUE LOS COMPUESTOS DE LAS FORMULAS ARRIBA MENCIONADAS Y EN PARTICULAR EL BUTILFTALURO, EL SEDANENOLURO Y EL SEDANOLURO (TANTO EN LAS FORMAS CIS COMO TRANS CONOCIDAS DE OTRO MODO COMO ACEITES ESENCIALES DERIVADOS PRINCIPALMENTE DE PLANTAS) IMITAN LA RESPUESTA FISIOLOGICA DE LOS ACIDOS GRASOS ESENCIALES Y TAMBIEN DE SUS ANALOGOS DE PROSTAGLANDINAS.
ES94918690T 1993-06-25 1994-06-24 Agente terapeutico. Expired - Lifetime ES2140541T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPL960593 1993-06-25

Publications (1)

Publication Number Publication Date
ES2140541T3 true ES2140541T3 (es) 2000-03-01

Family

ID=3777003

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94918690T Expired - Lifetime ES2140541T3 (es) 1993-06-25 1994-06-24 Agente terapeutico.

Country Status (12)

Country Link
EP (1) EP0708651B1 (es)
JP (1) JPH09505024A (es)
CN (1) CN1129908A (es)
AT (1) ATE185698T1 (es)
CA (1) CA2165794A1 (es)
DE (1) DE69421280T2 (es)
ES (1) ES2140541T3 (es)
IN (1) IN178310B (es)
NZ (1) NZ267567A (es)
PL (1) PL176595B1 (es)
WO (1) WO1995000157A1 (es)
ZA (1) ZA944568B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9821670D0 (en) * 1998-10-05 1998-12-02 Muhlbauer Roman C Plant extracts for the treatment of increased bone resorption
AUPP797598A0 (en) * 1998-12-30 1999-01-28 Butters, Desley Therapeutic agent
US6352728B1 (en) 1999-11-02 2002-03-05 International Celery Development Alliance Pty. Ltd. Extracts of celery seed for the prevention and treatment of pain, inflammation and gastrointestinal irritation
GB0211943D0 (en) * 2002-05-23 2002-07-03 Univ Sheffield Anti-helicobacter activity of celery seed components
ES2327639T3 (es) * 2003-05-14 2009-11-02 Dsm Ip Assets B.V. Uso de derivados de ftalida para el tratamiento y prevecion de diabetes mellitus.
CN100518733C (zh) 2003-09-23 2009-07-29 帝斯曼知识产权资产管理有限公司 用于治疗和预防糖尿病的组合物
CN1257711C (zh) 2003-12-05 2006-05-31 石药集团中奇制药技术（石家庄）有限公司 丁苯酞软胶囊及其制备工艺
KR20080015802A (ko) * 2005-05-24 2008-02-20 디에스엠 아이피 어셋츠 비.브이. 염증 질환의 치료를 위한 리구스틸라이드 유도체
JP2010500386A (ja) * 2006-08-11 2010-01-07 ディーエスエム アイピー アセッツ ビー．ブイ． 中枢神経系の障害を治療するためのリグスチリド誘導体
CN100569241C (zh) * 2007-01-17 2009-12-16 北京天川军威医药技术开发有限公司 芹菜籽乙酸乙酯萃取物及其用途
WO2010114686A2 (en) * 2009-03-11 2010-10-07 Johns Hopkins University Modulation of abcg2-mediated urate transport to treat hyperuricemia and gout
CN102844027A (zh) * 2009-11-23 2012-12-26 培力(香港)健康产品有限公司 治疗炎症和免疫系统障碍的新治疗方法
JP5581120B2 (ja) * 2010-06-07 2014-08-27 花王株式会社 電位依存性カチオンチャネル抑制剤
CN102697772A (zh) * 2012-05-08 2012-10-03 中国人民解放军第二军医大学 一种治疗痛风的药物组合物及其应用
CN103183654B (zh) * 2013-01-30 2014-11-05 泰山医学院 芹菜籽活性单体的分离纯化制备工艺
CN105535116A (zh) * 2015-12-23 2016-05-04 辽宁科技学院 一种天然药物提取物及其制备方法
CN110582480B (zh) 2017-04-21 2023-11-10 塔斯马尼亚大学 治疗化合物和方法
KR20210133463A (ko) * 2020-04-29 2021-11-08 한국 한의학 연구원 시라 추출물을 유효성분으로 함유하는 골질환의 예방, 개선 또는 치료용 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2334368A1 (fr) * 1975-12-10 1977-07-08 Unilever Nv Procede d'isolation, a partir des pepins de raisin, d'une substance a activite anti-inflammatoire, et composition pour la peau, contenant une telle substance
DE3040246C2 (de) * 1979-10-29 1985-01-10 Osaka Chemical Laboratory Co., Ltd., Osaka Sojasaponine A↓1↓ und A↓2↓ und ihre Verwendung
DE3347658A1 (de) * 1983-12-31 1985-07-11 Troponwerke GmbH & Co KG, 5000 Köln 1.4-naphthochinonderivate mit entzuendungshemmender wirkung
JPS61257155A (ja) * 1985-05-10 1986-11-14 Horiuchi:Kk 抗酸化食品
JPS63501288A (ja) * 1985-09-20 1988-05-19 ジ・アップジョン・カンパニ− １，４−ナフタレンジオ−ルおよび１，４−ヒドロキノン誘導体
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
FR2611502B1 (fr) * 1987-02-24 1990-03-09 Natura Medica Laboratoires Extrait de racines d'ombellifere obtenu par extraction hydroalcoolique, procede de preparation d'un tel extrait; et composition therapeutique, notamment a activite diuretique, cardiovasculaire, antalgique ou anti-inflammatoire comprenant un tel extrait
JPH02196767A (ja) * 1988-10-11 1990-08-03 Kyowa Hakko Kogyo Co Ltd ヒドロキサム酸誘導体
US5102883A (en) * 1989-10-31 1992-04-07 Du Pont Merck Pharmaceutical Company Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
IT1242020B (it) * 1990-11-20 1994-02-02 Sigma Tau Ind Farmaceuti Ftalidilidene derivati della carnitina e di alcanoil carnitine e composizioni farmaceutiche che li contengono.
AU653024B2 (en) * 1991-05-30 1994-09-15 Novartis Ag Substituted diaminophthalimides and analogues

Also Published As

Publication number Publication date
EP0708651A1 (en) 1996-05-01
EP0708651A4 (en) 1998-03-04
CA2165794A1 (en) 1995-01-05
IN178310B (es) 1997-03-22
DE69421280T2 (de) 2000-07-13
DE69421280D1 (de) 1999-11-25
NZ267567A (en) 1997-10-24
PL176595B1 (pl) 1999-06-30
WO1995000157A1 (en) 1995-01-05
CN1129908A (zh) 1996-08-28
PL312714A1 (en) 1996-05-13
JPH09505024A (ja) 1997-05-20
ZA944568B (en) 1995-03-20
EP0708651B1 (en) 1999-10-20
ATE185698T1 (de) 1999-11-15

Similar Documents

Publication Publication Date Title
ES2140541T3 (es) Agente terapeutico.
BR0109957A (pt) Método de modelagem de falha e fendimento na terra
BR9908222A (pt) Composições para regular a aparência da pele
SE7705382L (sv) Forfarande for framstellning av foreningar som lindrar angiotensinforbunden hypertension
ES2117052T3 (es) Induccion de respuestas de linfocitos t citotoxicos.
WO1999062510A3 (en) Compositions comprising anti-microtubule agents for treating or preventing inflammatory diseases
MX168000B (es) Complemento dietetico que contiene beta-glucan complemento
DE60329180D1 (de) Sebum- und schweissabsorbierendes grundierungsset und entsprechendes mehrstufiges verfahren
MX9301835A (es) Composiciones alimenticias de derivado de vitamina d y metodo de uso.
FR2405068A1 (fr) Composition pharmaceutique destinee au traitement du dessechement cutane
NO862409D0 (no) Preparat mot akner.
ATE283044T1 (de) Compactin zur behandlung von entzündungen
DK0727996T3 (da) Fendazolformuleringer
DK1023034T3 (da) Kosmetiske formuleringer til forebyggelse mod og behandling af hårtab
DK1438013T3 (da) Naturlig emulgator til kosmetik basiseret på olivenolie
ATE40946T1 (de) Arzneimittel oder prophylaktisches mittel zur behandlung von epilepsie.
NO20003758L (no) Trekonserveringsmidler
ATE183385T1 (de) Lyopilisierte, wirkstoffhaltige emulsion
JPS5714517A (en) Whitening cosmetic
ES2088826B1 (es) Procedimiento de obtencion de las diaminas putrescina y cadaverina a partir de productos naturales tratados, su uso como aditivo en abonos, y abono correspondiente.
DK1021433T3 (da) Fremgangsmåde til fremstilling af naturlige 1,3-diolderivater og tilsvarende naturlige 1,3-dioxanderivater
MX9302419A (es) Derivados de acido tetronico, tiotetronico y tetramico.
ES2177929T3 (es) Composicion cosmetica que contiene esteres de acido salicilico y retinoides.
WO2004052388A3 (en) Composition and method to whiten and exfoliate skin
ES2106800T3 (es) Composicion que contiene gamma octalactona, procedimiento de fermentacion para su produccion y usos organolepticos de la misma.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 708651

Country of ref document: ES